These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 25385370)
1. Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating β-catenin and cyclin D1 expression. Wang C; Guo Y; Wang J; Min Z Mol Med Rep; 2015 Mar; 11(3):2147-52. PubMed ID: 25385370 [TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway. Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946 [TBL] [Abstract][Full Text] [Related]
3. Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway. Chen L; Lin L; Xian N; Zheng Z Oncol Rep; 2019 Jul; 42(1):399-413. PubMed ID: 31115554 [TBL] [Abstract][Full Text] [Related]
4. [Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour]. Zhang H; Yao M; Qian Q; Shi Y; Li J; Chen X; Wang S; Yao D Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):620-4. PubMed ID: 25243965 [TBL] [Abstract][Full Text] [Related]
5. Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells. Zhang HJ; Yao DF; Yao M; Huang H; Wang L; Yan MJ; Yan XD; Gu X; Wu W; Lu SL World J Gastroenterol; 2013 Jun; 19(24):3792-801. PubMed ID: 23840117 [TBL] [Abstract][Full Text] [Related]
6. Expression and significance of Pin1, β-catenin and cyclin D1 in hepatocellular carcinoma. Ao R; Zhang DR; Du YQ; Wang Y Mol Med Rep; 2014 Oct; 10(4):1893-8. PubMed ID: 25109821 [TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil. Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731 [TBL] [Abstract][Full Text] [Related]
8. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma. Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318 [TBL] [Abstract][Full Text] [Related]
9. ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures. Shi H; Xiao L; Duan W; He H; Ma L; Da M; Duan Y; Wang Q; Wu H; Song X; Hou Y Micron; 2016 Jun; 85():26-33. PubMed ID: 27060670 [TBL] [Abstract][Full Text] [Related]
10. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748 [TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression. Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173 [TBL] [Abstract][Full Text] [Related]
13. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863 [TBL] [Abstract][Full Text] [Related]
14. Impact of Mucin1 knockdown on the phenotypic characteristics of the human hepatocellular carcinoma cell line SMMC-7721. Li Q; Wang F; Liu G; Yuan H; Chen T; Wang J; Xie F; Zhai R; Wang F; Guo Y; Ni W; Tai G Oncol Rep; 2014 Jun; 31(6):2811-9. PubMed ID: 24737121 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846 [TBL] [Abstract][Full Text] [Related]
16. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192 [TBL] [Abstract][Full Text] [Related]
17. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level. Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452 [TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. Jung KH; Kim JK; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Park WS; Lee JY; Nam SW J Cell Biochem; 2010 Jun; 110(3):687-96. PubMed ID: 20512928 [TBL] [Abstract][Full Text] [Related]
19. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin. Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095 [TBL] [Abstract][Full Text] [Related]
20. Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Sarkar S; Swiercz R; Kantara C; Hajjar KA; Singh P Gastroenterology; 2011 Feb; 140(2):583-595.e4. PubMed ID: 20826156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]